Literature DB >> 751807

Radioimmunoassay of human calcitonin using labeled [Asu1, 7]-human calcitonin analogue.

Y Okada, S Morimoto, T Onishi, K Tanaka, M Tsuji, Y Kumahara, S Tsushima, N Nakazawa, H Ogawa, S Sakakibara.   

Abstract

Application of synthetic human calcitonin analogue ([Asul,7]-hCT) was attempted, since it is chemically more stable than native hCT. [Asu1, 7]-hCT was successfully labeled with 125I to a specific activity ranging from 410 to 540 microCi/microgram. Sensitivity, recovery and reproducibility of the assay system using 125I-labeled [Asu1,7]-hCT analogue, standard synthetic hCT and its antibodies, were 49 pg/ml, 99.8 +/- 4%, and 7.95% (C. V. within assay) or 21.9% (C. V. between assays), respectively. The dilution curve of the sera obtained from patients with medullary carcinoma paralled well with the standard curve. 125-I-labeled [Asu1, 7]-hCT analogue can be used for routine radioimmunoassay of hCT.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 751807     DOI: 10.1507/endocrj1954.25.617

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  2 in total

1.  Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.

Authors:  A Miyauchi; T Onishi; S Morimoto; S Takai; F Matsuzuka; K Kuma; M Maeda; Y Kumahara
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

2.  Comparison of renal responses to synthetic human PTH(1-34) administration in normal young and elderly male subjects.

Authors:  S Imanaka; T Onishi; S Morimoto; S Takamoto; H Kohno; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.